Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine

Brian C. Gilger, Janice Andrews, David A. Wilkie, Milton Wyman, Michael Dale Lairmore

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Peripheral cellular immunity of ten dogs with keratoconjunctivitis sicca (KCS) that had not been treated with topical corticosteroids or cyclosporine was evaluated (by use of in vitro lymphocyte proliferation assays and CD4+ CD8+ lymphocyte subset analysis) before and after 1 and 3 months of treatment with topical ocular 2% cyclosporine (CsA). In vitro lymphocyte proliferation and CD4+ CD8+ lymphocyte subset analysis was done in eight normal dogs at the 0, 1 and 3 month time periods to use for comparison. There was no significant difference in lymphocyte proliferation or numbers of CD4+ or CD8+ lymphocytes in dogs with KCS and normal dogs prior to CsA treatment. However, by 1 month's time, lymphocyte proliferation had decreased in the CsA-treated Dogs with KCS, and by 3 months there was a significant difference (P<0.0001) from the normal dogs. These results suggest that dogs with KCS may not have altered peripheral cellular immunity and that use of topical 2% cyclosporine for treatment of KCS causes a suppression of lymphocyte proliferation after 1 to 3 months of use.

Original languageEnglish (US)
Pages (from-to)199-208
Number of pages10
JournalVeterinary Immunology and Immunopathology
Volume49
Issue number3
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Keratoconjunctivitis Sicca
keratoconjunctivitis
cyclosporine
Cellular Immunity
cell-mediated immunity
Cyclosporine
lymphocyte proliferation
Dogs
Lymphocytes
dogs
lymphocytes
Lymphocyte Subsets
lymphocyte count
adrenal cortex hormones
Adrenal Cortex Hormones
eyes
assays

Keywords

  • Canine
  • Cellular immunity
  • Cyclosporine
  • Keratoconjunctivitis sicca

ASJC Scopus subject areas

  • Immunology
  • veterinary(all)
  • Animal Science and Zoology

Cite this

Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine. / Gilger, Brian C.; Andrews, Janice; Wilkie, David A.; Wyman, Milton; Lairmore, Michael Dale.

In: Veterinary Immunology and Immunopathology, Vol. 49, No. 3, 1995, p. 199-208.

Research output: Contribution to journalArticle

@article{e2321d46ba924f51aff9ef7e387e550d,
title = "Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2{\%} cyclosporine",
abstract = "Peripheral cellular immunity of ten dogs with keratoconjunctivitis sicca (KCS) that had not been treated with topical corticosteroids or cyclosporine was evaluated (by use of in vitro lymphocyte proliferation assays and CD4+ CD8+ lymphocyte subset analysis) before and after 1 and 3 months of treatment with topical ocular 2{\%} cyclosporine (CsA). In vitro lymphocyte proliferation and CD4+ CD8+ lymphocyte subset analysis was done in eight normal dogs at the 0, 1 and 3 month time periods to use for comparison. There was no significant difference in lymphocyte proliferation or numbers of CD4+ or CD8+ lymphocytes in dogs with KCS and normal dogs prior to CsA treatment. However, by 1 month's time, lymphocyte proliferation had decreased in the CsA-treated Dogs with KCS, and by 3 months there was a significant difference (P<0.0001) from the normal dogs. These results suggest that dogs with KCS may not have altered peripheral cellular immunity and that use of topical 2{\%} cyclosporine for treatment of KCS causes a suppression of lymphocyte proliferation after 1 to 3 months of use.",
keywords = "Canine, Cellular immunity, Cyclosporine, Keratoconjunctivitis sicca",
author = "Gilger, {Brian C.} and Janice Andrews and Wilkie, {David A.} and Milton Wyman and Lairmore, {Michael Dale}",
year = "1995",
doi = "10.1016/0165-2427(95)05471-5",
language = "English (US)",
volume = "49",
pages = "199--208",
journal = "Veterinary Immunology and Immunopathology",
issn = "0165-2427",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Cellular immunity in dogs with keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine

AU - Gilger, Brian C.

AU - Andrews, Janice

AU - Wilkie, David A.

AU - Wyman, Milton

AU - Lairmore, Michael Dale

PY - 1995

Y1 - 1995

N2 - Peripheral cellular immunity of ten dogs with keratoconjunctivitis sicca (KCS) that had not been treated with topical corticosteroids or cyclosporine was evaluated (by use of in vitro lymphocyte proliferation assays and CD4+ CD8+ lymphocyte subset analysis) before and after 1 and 3 months of treatment with topical ocular 2% cyclosporine (CsA). In vitro lymphocyte proliferation and CD4+ CD8+ lymphocyte subset analysis was done in eight normal dogs at the 0, 1 and 3 month time periods to use for comparison. There was no significant difference in lymphocyte proliferation or numbers of CD4+ or CD8+ lymphocytes in dogs with KCS and normal dogs prior to CsA treatment. However, by 1 month's time, lymphocyte proliferation had decreased in the CsA-treated Dogs with KCS, and by 3 months there was a significant difference (P<0.0001) from the normal dogs. These results suggest that dogs with KCS may not have altered peripheral cellular immunity and that use of topical 2% cyclosporine for treatment of KCS causes a suppression of lymphocyte proliferation after 1 to 3 months of use.

AB - Peripheral cellular immunity of ten dogs with keratoconjunctivitis sicca (KCS) that had not been treated with topical corticosteroids or cyclosporine was evaluated (by use of in vitro lymphocyte proliferation assays and CD4+ CD8+ lymphocyte subset analysis) before and after 1 and 3 months of treatment with topical ocular 2% cyclosporine (CsA). In vitro lymphocyte proliferation and CD4+ CD8+ lymphocyte subset analysis was done in eight normal dogs at the 0, 1 and 3 month time periods to use for comparison. There was no significant difference in lymphocyte proliferation or numbers of CD4+ or CD8+ lymphocytes in dogs with KCS and normal dogs prior to CsA treatment. However, by 1 month's time, lymphocyte proliferation had decreased in the CsA-treated Dogs with KCS, and by 3 months there was a significant difference (P<0.0001) from the normal dogs. These results suggest that dogs with KCS may not have altered peripheral cellular immunity and that use of topical 2% cyclosporine for treatment of KCS causes a suppression of lymphocyte proliferation after 1 to 3 months of use.

KW - Canine

KW - Cellular immunity

KW - Cyclosporine

KW - Keratoconjunctivitis sicca

UR - http://www.scopus.com/inward/record.url?scp=0029608817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029608817&partnerID=8YFLogxK

U2 - 10.1016/0165-2427(95)05471-5

DO - 10.1016/0165-2427(95)05471-5

M3 - Article

VL - 49

SP - 199

EP - 208

JO - Veterinary Immunology and Immunopathology

JF - Veterinary Immunology and Immunopathology

SN - 0165-2427

IS - 3

ER -